These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 30126964

  • 1. In Vitro Susceptibility Testing of a Novel Benzimidazole, SPR719, against Nontuberculous Mycobacteria.
    Brown-Elliott BA, Rubio A, Wallace RJ.
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126964
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method.
    Sharma M, Malhotra B, Khandelwal S.
    Indian J Med Microbiol; 2021 Jul; 39(3):306-310. PubMed ID: 33846029
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Benzimidazole SPR719 Shows Promising Concentration-Dependent Activity and Synergy against Nontuberculous Mycobacteria.
    Pennings LJ, Ruth MM, Wertheim HFL, van Ingen J.
    Antimicrob Agents Chemother; 2021 Mar 18; 65(4):. PubMed ID: 33468478
    [Abstract] [Full Text] [Related]

  • 10. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
    Litvinov V, Makarova M, Galkina K, Khachaturiants E, Krasnova M, Guntupova L, Safonova S.
    PLoS One; 2018 Mar 18; 13(9):e0203108. PubMed ID: 30222736
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
    Gitti Z, Mantadakis E, Maraki S, Samonis G.
    Future Microbiol; 2011 Sep 18; 6(9):1099-109. PubMed ID: 21958147
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel.
    Hershko Y, Adler A.
    Microb Drug Resist; 2023 Jul 18; 29(7):302-308. PubMed ID: 37219996
    [Abstract] [Full Text] [Related]

  • 18. In Vitro Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus.
    Aragaw WW, Cotroneo N, Stokes S, Pucci M, Critchley I, Gengenbacher M, Dick T.
    Microbiol Spectr; 2022 Feb 23; 10(1):e0132121. PubMed ID: 35019671
    [Abstract] [Full Text] [Related]

  • 19. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW, Chen JH, Hu ST, Huang WC, Lee YC, Huang CC, Shen GH.
    Int J Antimicrob Agents; 2013 Mar 23; 41(3):218-23. PubMed ID: 23312605
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection.
    Cotroneo N, Stokes SS, Pucci MJ, Rubio A, Hamed KA, Critchley IA.
    J Antimicrob Chemother; 2024 Apr 02; 79(4):875-882. PubMed ID: 38394463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.